From October 1, 2023 to December 31, 2023, the company has repurchased 932,000 shares, representing 0.47% for CNY 10.08 million. With this, the company has completed the repurchase of 1,105,000 shares, representing 0.56% for CNY 13.4 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.7 CNY | -0.90% | -3.54% | -18.47% |
1st Jan change | Capi. | |
---|---|---|
-18.47% | 482M | |
+39.82% | 734B | |
+32.57% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+14.25% | 238B | |
-6.30% | 204B | |
+8.78% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.